Tick-borne encephalitis (TBE) is an acute febrile illness with neurological manifestations that is prevalent in forested areas of moderate climate in Europe and Asia. TBE virus is transmitted by ticks and rarely by unpasteurized milk and dairy products. The disease burden is attributed mainly to resulting long-term disability, especially in individuals over 50 y of age. Currently, there is no causative treatment, but a very effective vaccination is available with a good safety profile. The vaccination requires 3 basic doses to be fully effective and regular boosters afterwards. An accelerated vaccination schedule enables a patient to reach reasonably protective titres within 3 to 4 weeks from the first injection. The risk of travel-related TBE is estimated to be less than the risk of acquiring typhoid fever while visiting highly endemic regions in South Asia, but more than the risk of acquiring Japanese encephalitis, meningococcal invasive disease, or rabies. The pre-travel risk assessment of acquiring TBE should consider known risk factors which include 1) the country and regions to be visited; 2) April to November season; 3) altitude less than 1500 m above the sea level; 4) duration of stay; 5) the extent of tick-exposure associated activities including leisure and professional outdoor activities within the endemic area; and 6) age and comorbidities of the traveler. A major challenge, however, is the very low awareness of the risk of contracting TBE in those who travel to industrialized European countries.

b Tropical and Infectious Disease Unit Royal Liverpool University Hospital Liverpool UK

c Institute of Parasitology Biology Centre of the Czech Academy of Sciences Ceske Budejovice and Veterinary Research Institute Brno Czech Republic

Department of Infectious Diseases Ceske Budejovice Hospital České Budĕjovice Czech Republic

Zobrazit více v PubMed

Růžek D, Dobler G, Donoso Mantke O. Tick-borne encephalitis: pathogenesis and clinical implications. Travel Med Infect Dis 2010; 8:223-32; http://dx.doi.org/10.1016/j.tmaid.2010.06.004 PubMed DOI

Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet 2008; 371:1861-71; PMID:18514730; http://dx.doi.org/10.1016/S0140-6736(08)60800-4 PubMed DOI

Amicizia D, Domnich A, Panatto D, Lai PL, Cristina ML, Avio U, Gasparini R. Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines. Hum Vaccin Immunother 2013; 9:1163-71; PMID:23377671; http://dx.doi.org/10.4161/hv.23802 PubMed DOI PMC

Rendi-Wagner P, Jeschko E, Kollaritsch H. Oesterreichische Expertengruppe für Reisemedizin. Travel vaccination recommendations for Central and Eastern European countries based on countryspecific risk profiles. Wien Klin Wochenschr 2005; 117(Suppl 4):11-9; PMID:16416380; http://dx.doi.org/10.1007/s00508-005-0442-8 PubMed DOI

Kollaritsch H, Krasilnikov V, Holzmann H, Karganova G, Barrett A, Süss J, Pervikov Y, Bjorvatn B, Duclos P, Hombach J. Background document on vaccines and vaccination against tick-borne encephalitis (TBE) WHO Position Paper Geneva: WHO Strategic Advisory Group of experts on immunization; Available at: http://www.who.int/immunization/sage/6_TBE_backgr_18_Mar_net_apr_2011.pdf, Last accessed June2016

Wu XB, Na RH, Wei SS, Zhu JS, Peng HJ. Distribution of tick-borne diseases in China. Parasit Vectors 2013; 6:119; PMID:23617899; http://dx.doi.org/10.1186/1756-3305-6-119 PubMed DOI PMC

Kim SY, Yun SM, Han MG, Lee IY, Lee NY, Jeong YE, Lee BC, Ju YR. Isolation of tick-borne encephalitis viruses from wild rodents, South Korea. Vector Borne Zoonotic Dis 2008; 8:7-13; PMID:18240970; http://dx.doi.org/10.1089/vbz.2006.0634 PubMed DOI

Ko S, Kang JG, Kim SY, Kim HC, Klein TA, Chong ST, Sames WJ, Yun SM, Ju YR, Chae JS. Prevalence of tick-borne encephalitis virus in ticks from southern Korea. J Vet Sci 2010; 11:197-203; PMID:20706026; http://dx.doi.org/10.4142/jvs.2010.11.3.197 PubMed DOI PMC

European Centers for Disease Prevention and Control Annual epidemiological report 2014 — emerging and vector borne diseases Stockholm: ECDC, 2014:20-3.

Kunze U. Is there a need for a travel vaccination against tick-borne encephalitis? Travel Med Infect Dis 2008; 6:380-3; PMID:18984485; http://dx.doi.org/10.1016/j.tmaid.2008.06.004 PubMed DOI

Reusken C, Reimerink J, Verduin C, Sabbe L, Cleton N, Koopmans M. Case report: Tick-borne encephalitis in two Dutch travellers returning from Austria, Netherlands, July and August 2011. Euro Surveill 2011; 16(44):20003; PMID:22085619 PubMed

Centers for Disease Control and Prevention (CDC) . Tick-borne encephalitis among US travelers to Europe and Asia - 2000–2009. MMWR Morb Mortal Wkly Rep 2010; 59:335-8; PMID:20339345 PubMed

Chaudhuri A, Růžek D. First documented case of imported tick-borne encephalitis in Australia. Intern Med J 2013; 43:93-6; PMID:23324091; http://dx.doi.org/10.1111/imj.12017 PubMed DOI

Public Health England http://webarchive.nationalarchives.gov.uk/20140714084352/ http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/TickborneEncephalitis/ Last accessed June2016

Steffen R. Epidemiology of tick-borne encephalitis (TBE) in international travellers to Western/Central Europe and conclusions on vaccination recommendations. J Travel Med 2016; 23(4):taw018; PMID:27087558 PubMed

Haditsch M, Kunze U. Tick-borne encephalitis: a disease neglected by travel medicine. Travel Med Infect Dis 2013; 11:295-300; PMID:23916617 PubMed

Chrdle A, Mallátová N, Vašáková M, Haber J, Denning DW. Burden of serious fungal infections in the Czech Republic. Mycoses 2015; 58 Suppl 5:6-14; PMID:26449501 PubMed

Kunze U. the ISW-TBE. Tick-borne encephalitis (TBE): Report of the 14th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISWTBE). Ticks Tick Borne Dis 2012; 3:197-201; PMID:22765977 PubMed

European Centre for Disease Prevention and Control Epidemiological situation of tick-borne encephalitis in the European Union and European Free Trade Association countries. Stockholm: ECDC; 2012.

Ergunay K, Tkachev S, Kozlova I, Růžek D. A Review of Methods for Detecting Tick-Borne Encephalitis Virus Infection in Tick, Animal, and Human Specimens. Vector Borne Zoonotic Dis 2016; 16:4-12; PMID:26771446 PubMed

Mansfield KL, Horton DL, Johnson N, Li L, Barrett AD, Smith DJ, Galbraith SE, Solomon T, Fooks AR. Flavivirus-induced antibody cross-reactivity. J Gen Virol 2011; 92(Pt 12):2821-9; PMID:21900425 PubMed PMC

Yoshii K, Ikawa A, Chiba Y, Omori Y, Maeda J, Murata R, Kariwa H, Takashima I. Establishment of a neutralization test involving reporter gene-expressing virus-like particles of tick-borne encephalitis virus. J Virol Methods 2009; 161:173-6; PMID:19481114 PubMed

Veje M, Studahl M, Norberg P, Roth A, Möbius U, Brink M, Bergström T. Detection of tick-borne encephalitis virus RNA in urine. J Clin Microbiol 2014; 52:4111-2; PMID:25165082 PubMed PMC

Broeker M. Following a tick bite: double infections by tick-borne encephalitis virus and the spirochete Borrelia and other potential multiple infections. Zoonoses Public Health 2012; 59:176-80; PMID:21848518 PubMed

Lotric-Furlan S, Petrovec M, Avsic-Zupanc T, Strle F. Concomitant tickborne encephalitis and human granulocytic ehrlichiosis. Emerg Infect Dis 2005; 11:485-8; PMID:15757574 PubMed PMC

Kaiser R. Tick-borne encephalitis: Clinical findings and prognosis in adults. Wien Med Wochenschr 2012; 162:239-43; PMID:22695809 PubMed

Rostasy K. Tick-borne encephalitis in children. Wien Med Wochenschr 2012; 162:244-7; PMID:22688618 PubMed

Šmit R, Postma MJ. The burden of tick-borne encephalitis in disability-adjusted life years (DALYs) for Slovenia. PLoS One 2015; 10:e0144988. PubMed PMC

Chmelik V, Bouzkova M, Houserova L, Zdvorak J, Sirkova I, Slamova I, Jerhotova Z, Trnovcova R, Chrdle A, Cihlova V, et al.. Clinical picture of TBE; a retrospective study of 493 cases. Zentralbl Bakteriol 1999; 289:583-4.

Sprong H, Trentelman J, Seemann I, Grubhoffer L, Rego RO, Hajdušek O, Kopáček P, Šíma R, Nijhof AM, Anguita J, et al.. ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe. Parasit Vectors 2014; 7:77; PMID:24559082 PubMed PMC

Jensenius M, Parola P, Raoult D. Threats to international travellers posed by tick-borne diseases. Travel Med Infect Dis 2006; 4:4-13; PMID:16887719 PubMed

Banzhoff A, Broeker M, Zent O. Protection against tick-borne encephalitis (TBE) for people living in and travelling to TBE-endemic areas. Travel Med Infect Dis 2008; 6:331-41; PMID:18984477 PubMed

Bogovic P, Strle F. Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management. World J Clin Cases 2015; 3:430-41; PMID:25984517 PubMed PMC

Heinz FX. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine 2007; 25:7559-67; PMID:17869389 PubMed

TicoVac SP. Available at: https://www.medicines.org.uk/emc/medicine/30324, Last accessed June2016

Hombach J, Barrett AD, Kollaritsch H. Vaccines against tick-borne encephalitis In Plotkin S, Orenstein W, Offit P (eds). Vaccine, 7th edn. USA: Elsevier INC, 2016. (in press)

Domnich A, Panatto D, Arbuzova EK, Signori A, Avio U, Gasparini R, Amicizia D. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis. Hum Vaccin Immunother 2014; 10:2819-33; PMID:25483679 PubMed PMC

Prymula R, Pöllabauer EM, Pavlova BG, Löw-Baselli A, Fritsch S, Angermayr R, Geisberger A, Barrett PN, Ehrlich HJ. Antibody persistence after two vaccinations with either FSME-IMMUNR Junior or ENCEPURR Children followed by third vaccination with FSME-IMMUNR Junior. Hum Vaccin Immunother 2012; 8:736-42; PMID:22699436 PubMed

Schoendorf I, Ternak G, Oroszlan G, Nicolay U, Banzhoff A, Zent O. Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21). Hum Vaccin 2007; 3:42-7; PMID:17297298 PubMed

Schondorf I, Beran J, Cizkova D, Lesna V, Banzhoff A, Zent O. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule. Vaccine 2007; 25:1470-5; PMID:17196713 PubMed

Süss J, Kahl O, Aspöck H, Hartelt K, Vaheri A, Oehme R, Hasle G, Dautel H, Kunz C, Kupreviciene N, et al.. Tick-borne encephalitis in the age of general mobility. Wien Med Wochenschr 2010; 160:94-100; PMID:20300927 PubMed

The structure of immature tick-borne encephalitis virus supports the collapse model of flavivirus maturation

Experimental and Natural Infections of Tick-Borne Encephalitis Virus in Dogs

Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses

Tick-Borne Encephalitis Virus Vaccines Contain Non-Structural Protein 1 Antigen and may Elicit NS1-Specific Antibody Responses in Vaccinated Individuals